Interestingly, in murine and human breast cancers, TEMs express lymphatic markers (e.g., LYVE 1, VEGFR-3, and podoplanin) and lymphangiogenic factors (VEGF-C and VEGF-D) and are associated with lymphatic structures [123]. The gene discussed is PDPN; the disease is breast cancer.